- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Business Development Office
- Partnering opportunities
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Improving vision outcomes in retinal detachment
- Intercepting inflammation with RIPK2 inhibitors
- Novel inhibitors for the treatment of lupus
- Novel malaria vaccine
- Novel mucolytics for the treatment of respiratory diseases
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting minor class splicing
- Partnerships and collaborations
- Royalties distribution
- Start-up companies
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- People
- Anne-Laure Puaux
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Emma Josefsson
- Associate Professor Ethan Goddard-Borger
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Leanne Robinson
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Sant-Rayn Pasricha
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gemma Kelly
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Joanna Groom
- Dr John Wentworth
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Shabih Shakeel
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- A new regulator of stemness to create dendritic cell factories for immunotherapy
- Advanced methods for genomic rearrangement detection
- Control of cytokine signaling by SOCS1
- Defining the protein modifications associated with respiratory disease
- Delineating the pathways driving cancer development and therapy resistance
- Developing a new drug that targets plasmacytoid dendritic cells for the treatment of lupus
- Development and mechanism of action of novel antimalarials
- Development of a novel particle-based malaria vaccine
- Development of tau-specific therapeutic and diagnostic antibodies
- Discovering novel therapies for major human pathogens
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Epigenetic biomarkers of tuberculosis infection
- Essential role of glycobiology in malaria parasites
- Evolution of haematopoiesis in vertebrates
- Human lung protective immunity to tuberculosis
- Identifying novel treatment options for ovarian carcinosarcoma
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of mutant p53 in cancer
- Microbiome strain-level analysis using long read sequencing
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Modelling spatial and demographic heterogeneity of malaria transmission risk
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Structural basis of catenin-independent Wnt signalling
- Structure and biology of proteins essential for Toxoplasma parasite invasion
- T lymphocytes: how memories are made
- TICKER: A cell history recorder for longitudinal patient monitoring
- Targeting host pathways to develop new broad-spectrum antiviral drugs
- Targeting post-translational modifications to disrupting the function of secreted proteins
- Targeting the epigenome to rewire pro-allergic T cells
- Targeting the immune microenvironment to treat KRAS-mutant adenocarcinoma
- The E3 ubiquitin ligase Parkin and mitophagy in Parkinson’s disease
- The molecular controls on dendritic cell development
- Understanding malaria infection dynamics
- Understanding the genetics of neutrophil maturation
- Understanding the neuroimmune regulation of innate immunity
- Understanding the proteins that regulate programmed cell death at the molecular level
- Using cutting-edge single cell tools to understand the origins of cancer
- When healthy cells turn bad: how immune responses can transition to lymphoma
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Institute enters global top 20 on Nature Index
21 June 2019
The 2019 Nature Index has ranked Melbourne’s Walter and Eliza Hall Institute in the top 20 global not-for-profit/non-governmental organisations in biomedical sciences.
as the top-ranked Australian medical research institute, and
19th amongst not-for-profit/non-governmental organisations
worldwide.
The index compares organisations by their contribution to publications in leading biomedical research journals, as a measure of scientific excellence.
The Walter and Eliza Hall Institute was the top-ranked Australian medical research institute, and placed 19th amongst organisations worldwide.
At a glance
- The Walter and Eliza Hall Institute has been ranked 19th in the 2019 Nature Index for not-for-profit/non-governmental organisations in biomedical sciences.
- The Institute was the top-placed Australian medical research Institute in the index, which compares organisations’ scientific publications.
- The Institute’s ranking was influenced by publications unravelling fundamental biology as well as developing new therapies for a range of diseases.
International recognition
Walter and Eliza Hall Institute director Professor Doug Hilton said the Institute’s ranking was a reflection of the Institute’s international standing as a biomedical research Institute.
Professor Wai-Hong Tham led research that was published in the
high-ranking journals Nature and Science in 2018.
“The Institute is known in Australia and around the word for its longstanding scientific excellence and game-changing discoveries. I am proud to see this recognised in our position in the Nature Index, alongside other world-class research organisations in Europe and the United States,” he said.
The Nature Index ranks research organisations on the basis of their contributions to research publications across 82 high-quality science journals. Professor Hilton said that publications were just one measure of the Institute’s scientific excellence.
“We also place a high value on collaboration, translation, community engagement and education, and our success can also be seen in the impact of our research discoveries on health, and the calibre of our staff, students and alumni,” he said.
“Our success as a medical research Institute is not just due to the authors of research papers, but to all the research staff and students, as well as our Professional Services teams, mentors, collaborators and supporters who make great medical research achievable.”
Broad impact on medical research
The Nature Index reflects the Institute’s publications across a broad range of multidisciplinary medical research. These spanned the Institute’s research themes of Infection, Inflammation and Immunity; Cancer Research and Treatments; Healthy Development and Ageing; Computational Biology; and New Medicines and Advanced Technologies.
Among the ground-breaking research publications from the Institute in 2018 were :
- The identification and mapping of the molecules that allow the malaria parasite to invade human red blood cells, potentially providing a blueprint for new antimalarial drugs or vaccines – research led by Associate Professor Wai-Hong Tham and Dr Jakub Gruszczyk, and published in the journals Nature and Science.
- The discovery of how the immune system helps maintain ‘good’ bacteria in the gut, reducing inflammation and protecting against inflammatory bowel disease – research led by Associate Professor Seth Masters, Dr Tracy Putoczki and Dr Alan Yu, in collaboration with University of Melbourne’s Bio21 Institute and QIMR Berghofer, and published in Nature Communications.
- The development of a new class of anti-cancer drug that puts cancer cells into a permanent sleep – led by Associate Professor Tim Thomas and Associate Professor Anne Voss in collaboration with Monash Institute of Pharmaceutical Sciences and Cancers Therapeutics CRC, and published in Nature.
- Combining immunology and bioinformatics expertise to reveal how immune health is maintained by meticulously ordered DNA – led by Dr Rhys Allan, Dr Tim Johanson, Professor Stephen Nutt, Professor Gordon Smyth and Dr Hannah Coughlan, published in Nature Immunology.
- The revelation that while programmed cell death – or apoptosis – is essential for healthy development overall, many organs and tissues do not require apoptosis to develop normally – a collaboration between teams led by Associate Professor Anne Voss and Professor Andreas Strasser, with collaborators at Monash University and Genentech (a member of the Roche Group), and published in the journal Cell.
Research at the Walter and Eliza Hall Institute is made possible by the support of the Australian Government, the Victorian Government and our many generous philanthropic donors.
Media enquiries
M: +61 475 751 811
E: communityrelations@wehi.edu.au
Super Content:
WEHI has a strong history of significant discoveries of clinical importance and an outstanding international reputation.
Explore the current opportunities to join our team.
Nature Index ranks the Institute as the top medical research institute in Australia
Want to hear about our latest discoveries? Subscribe to our supporter newsletter, Illuminate.